Compare $PROK vs $RGNX | Chartloom

Compare

$PROK vs $RGNX

Prokidney Corp · Regenxbio Inc

PROK

Prokidney Corp

RGNX

Regenxbio Inc

Compare $PROK vs $RGNX

Comparing Prokidney Corp and Regenxbio Inc

PROKProkidney Corp

RGNXRegenxbio Inc

PROKProkidney Corp

Market cap

$526M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

788.85x

Rev growth (TTM)

55.2%

YTD performance

-22.0%

52W performance

-46.6%

FCF yield

-30.4%

RGNXRegenxbio Inc

Market cap

$511M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.95x

Rev growth (TTM)

12.0%

YTD performance

-40.5%

52W performance

-34.0%

FCF yield

-48.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PROK

RGNX

Detailed metrics comparison

PROK

Prokidney Corp

RGNX

Regenxbio Inc

Market Cap

PROK$526M

RGNX$511M

Enterprise Value

PROK$451M

RGNX$656M

Price

PROK$1.74

RGNX$8.07

P/E Ratio

PROKN/A

RGNXN/A

P/S Ratio

PROK642.52x

RGNX2.93x

EV/Sales

PROK551.08x

RGNX3.76x

EV/EBITDA

PROK0.00x

RGNX5.30x

P/B Ratio

PROK78.79x

RGNX6.83x

P/FCF Ratio

PROKN/A

RGNXN/A

EV/FCF

PROK-2.82x

RGNX-2.63x

PEG Ratio

PROKN/A

RGNXN/A

Forward P/E (NTM)

PROKN/A

RGNXN/A

Forward P/S (NTM)

PROK788.85x

RGNX5.95x

Revenue (TTM)

PROK$818K

RGNX$174M

Revenue Growth (YoY)

PROK55.2%

RGNX12.0%

Forward Rev Growth

PROK-44.4%

RGNX25.9%

Gross Margin (TTM)

PROK0.0%

RGNX86.4%

Operating Margin (TTM)

PROK0.0%

RGNX0.0%

EBITDA Margin (TTM)

PROK-20827.6%

RGNX-85.3%

Net Margin (TTM)

PROK-10288.4%

RGNX-112.6%

FCF Margin (TTM)

PROK-19527.4%

RGNX-143.1%

Net Income (TTM)

PROK$-84M

RGNX$-196M

FCF (TTM)

PROK$-160M

RGNX$-250M

EPS (TTM)

PROK-$0.45

RGNX-$3.71

ROE (TTM)

PROK-2810.2%

RGNX-22007.0%

ROA (TTM)

PROK-2739.0%

RGNX-4604.0%

ROIC (TTM)

PROK0.0%

RGNX-7179.0%

Cash

PROK$75M

RGNX$36M

Debt

PROK$67K

RGNX$182M

Net Cash/Debt

PROK$75M

RGNX$-145M

Current Ratio (TTM)

PROK8.36x

RGNX2.86x

Quick Ratio (TTM)

PROK8.07x

RGNX2.71x

Debt/Equity (TTM)

PROK5.40x

RGNX2.53x

Debt/Assets (TTM)

PROK0.0%

RGNX0.0%

Interest Coverage (TTM)

PROKN/A

RGNXN/A

Net Debt/EBITDA (TTM)

PROK0.00x

RGNX0.00x

Beta

PROK1.95

RGNX1.21

52W Performance

PROK-46.6%

RGNX-34.0%

YTD Performance

PROK-22.0%

RGNX-40.5%

% from 52W High

PROK-50.0%

RGNX-50.2%

% from 52W Low

PROK33.8%

RGNX47.9%

Asset Turnover (TTM)

PROK0.00x

RGNX0.41x

FCF Yield (TTM)

PROK-30.4%

RGNX-48.9%

Earnings Yield (TTM)

PROK-16.0%

RGNX-38.5%

Dividend Yield (TTM)

PROKN/A

RGNXN/A

Rule of 40

PROK-19,472.2

RGNX-131.1

EV/GP/RG

PROKN/A

RGNX0.15

Ticker research

View PROK research View RGNX research

Metric	PROK Prokidney Corp	RGNX Regenxbio Inc
Market & Valuation
Market Cap	$526M	$511M
Enterprise Value	$451M	$656M
Price	$1.74	$8.07
P/E Ratio	N/A	N/A
P/S Ratio	642.52x	2.93x
EV/Sales	551.08x	3.76x
EV/EBITDA	0.00x	5.30x
P/B Ratio	78.79x	6.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.82x	-2.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	788.85x	5.95x
Revenue & Growth
Revenue (TTM)	$818K	$174M
Revenue Growth (YoY)	55.2%	12.0%
Forward Rev Growth	-44.4%	25.9%
Profitability
Gross Margin (TTM)	0.0%	86.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-20827.6%	-85.3%
Net Margin (TTM)	-10288.4%	-112.6%
FCF Margin (TTM)	-19527.4%	-143.1%
Net Income (TTM)	$-84M	$-196M
FCF (TTM)	$-160M	$-250M
EPS (TTM)	-$0.45	-$3.71
ROE (TTM)	-2810.2%	-22007.0%
ROA (TTM)	-2739.0%	-4604.0%
ROIC (TTM)	0.0%	-7179.0%
Financial Health
Cash	$75M	$36M
Debt	$67K	$182M
Net Cash/Debt	$75M	$-145M
Current Ratio (TTM)	8.36x	2.86x
Quick Ratio (TTM)	8.07x	2.71x
Debt/Equity (TTM)	5.40x	2.53x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	1.21
52W Performance	-46.6%	-34.0%
YTD Performance	-22.0%	-40.5%
% from 52W High	-50.0%	-50.2%
% from 52W Low	33.8%	47.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.41x
FCF Yield (TTM)	-30.4%	-48.9%
Earnings Yield (TTM)	-16.0%	-38.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-19,472.2	-131.1
EV/GP/RG	N/A	0.15
Ticker research	View PROK research	View RGNX research

Valuation

P/S Ratio

RGNX

2.93x

PROK

642.52x

EV/FCF

PROK

-2.82x

RGNX

-2.63x

Growth & revenue

Revenue Growth TTM

PROK

55.2%

RGNX

12.0%

Forward Revenue Growth

RGNX

25.9%

PROK

-44.4%

Profitability & performance

Gross Margin

RGNX

86.4%

PROK

0.0%

ROE

PROK

-2810.2%

RGNX

-22007.0%

FCF Yield %

PROK

-30.4%

RGNX

-48.9%

52-Week Performance

RGNX

-34.0%

PROK

-46.6%

Detailed metrics comparison

PROK

Prokidney Corp

RGNX

Regenxbio Inc

Market Cap

PROK$526M

RGNX$511M

Enterprise Value

PROK$451M

RGNX$656M

Price

PROK$1.74

RGNX$8.07

P/E Ratio

PROKN/A

RGNXN/A

P/S Ratio

PROK642.52x

RGNX2.93x

EV/Sales

PROK551.08x

RGNX3.76x

EV/EBITDA

PROK0.00x

RGNX5.30x

P/B Ratio

PROK78.79x

RGNX6.83x

P/FCF Ratio

PROKN/A

RGNXN/A

EV/FCF

PROK-2.82x

RGNX-2.63x

PEG Ratio

PROKN/A

RGNXN/A

Forward P/E (NTM)

PROKN/A

RGNXN/A

Forward P/S (NTM)

PROK788.85x

RGNX5.95x

Revenue (TTM)

PROK$818K

RGNX$174M

Revenue Growth (YoY)

PROK55.2%

RGNX12.0%

Forward Rev Growth

PROK-44.4%

RGNX25.9%

Gross Margin (TTM)

PROK0.0%

RGNX86.4%

Operating Margin (TTM)

PROK0.0%

RGNX0.0%

EBITDA Margin (TTM)

PROK-20827.6%

RGNX-85.3%

Net Margin (TTM)

PROK-10288.4%

RGNX-112.6%

FCF Margin (TTM)

PROK-19527.4%

RGNX-143.1%

Net Income (TTM)

PROK$-84M

RGNX$-196M

FCF (TTM)

PROK$-160M

RGNX$-250M

EPS (TTM)

PROK-$0.45

RGNX-$3.71

ROE (TTM)

PROK-2810.2%

RGNX-22007.0%

ROA (TTM)

PROK-2739.0%

RGNX-4604.0%

ROIC (TTM)

PROK0.0%

RGNX-7179.0%

Cash

PROK$75M

RGNX$36M

Debt

PROK$67K

RGNX$182M

Net Cash/Debt

PROK$75M

RGNX$-145M

Current Ratio (TTM)

PROK8.36x

RGNX2.86x

Quick Ratio (TTM)

PROK8.07x

RGNX2.71x

Debt/Equity (TTM)

PROK5.40x

RGNX2.53x

Debt/Assets (TTM)

PROK0.0%

RGNX0.0%

Interest Coverage (TTM)

PROKN/A

RGNXN/A

Net Debt/EBITDA (TTM)

PROK0.00x

RGNX0.00x

Beta

PROK1.95

RGNX1.21

52W Performance

PROK-46.6%

RGNX-34.0%

YTD Performance

PROK-22.0%

RGNX-40.5%

% from 52W High

PROK-50.0%

RGNX-50.2%

% from 52W Low

PROK33.8%

RGNX47.9%

Asset Turnover (TTM)

PROK0.00x

RGNX0.41x

FCF Yield (TTM)

PROK-30.4%

RGNX-48.9%

Earnings Yield (TTM)

PROK-16.0%

RGNX-38.5%

Dividend Yield (TTM)

PROKN/A

RGNXN/A

Rule of 40

PROK-19,472.2

RGNX-131.1

EV/GP/RG

PROKN/A

RGNX0.15

Ticker research

View PROK research View RGNX research

Metric	PROK Prokidney Corp	RGNX Regenxbio Inc
Market & Valuation
Market Cap	$526M	$511M
Enterprise Value	$451M	$656M
Price	$1.74	$8.07
P/E Ratio	N/A	N/A
P/S Ratio	642.52x	2.93x
EV/Sales	551.08x	3.76x
EV/EBITDA	0.00x	5.30x
P/B Ratio	78.79x	6.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.82x	-2.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	788.85x	5.95x
Revenue & Growth
Revenue (TTM)	$818K	$174M
Revenue Growth (YoY)	55.2%	12.0%
Forward Rev Growth	-44.4%	25.9%
Profitability
Gross Margin (TTM)	0.0%	86.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-20827.6%	-85.3%
Net Margin (TTM)	-10288.4%	-112.6%
FCF Margin (TTM)	-19527.4%	-143.1%
Net Income (TTM)	$-84M	$-196M
FCF (TTM)	$-160M	$-250M
EPS (TTM)	-$0.45	-$3.71
ROE (TTM)	-2810.2%	-22007.0%
ROA (TTM)	-2739.0%	-4604.0%
ROIC (TTM)	0.0%	-7179.0%
Financial Health
Cash	$75M	$36M
Debt	$67K	$182M
Net Cash/Debt	$75M	$-145M
Current Ratio (TTM)	8.36x	2.86x
Quick Ratio (TTM)	8.07x	2.71x
Debt/Equity (TTM)	5.40x	2.53x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	1.21
52W Performance	-46.6%	-34.0%
YTD Performance	-22.0%	-40.5%
% from 52W High	-50.0%	-50.2%
% from 52W Low	33.8%	47.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.41x
FCF Yield (TTM)	-30.4%	-48.9%
Earnings Yield (TTM)	-16.0%	-38.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-19,472.2	-131.1
EV/GP/RG	N/A	0.15
Ticker research	View PROK research	View RGNX research